for underrepresented populations
A primary goal of research is to discover new knowledge for the public good. Yet many segments of the public—including minorities, women, and the elderly—historically have been underrepresented in clinical research. And that affects the research results.
In the short term, patients from underrepresented populations are less likely to be among those who benefit from discoveries made during clinical trials. Longer term, without equitable representation, researchers cannot be sure that study results apply equally well to different populations. In essence, those who are left out of the study run the risk of being left out of the cure.
With our partners in healthcare, academia, government, and industry, Clinical Research Pathways seeks to increase diversity by reducing barriers to research participation and engagement. Together, we encourage physicians, patients, and research participants from underrepresented populations to become involved in research-related efforts.
Our goals include but are not limited to:
- Building trust between underrepresented populations and the research community.
- Engaging physicians in recruiting underrepresented populations for clinical research.
- Making clinical trials more accessible to patients in communities with larger underrepresented populations.
- Reaching out to underrepresented populations about the importance and benefits of research.
To support Clinical Research Pathways and this important program, click here.